Citic Securities Company Limited(600030)
About Apt Medical Inc(688617)
Special verification opinions on the deposit and use of raised funds in 2021
Citic Securities Company Limited(600030) (hereinafter referred to as ” Citic Securities Company Limited(600030) ” or “sponsor”) is the continuous supervision sponsor of Apt Medical Inc(688617) (hereinafter referred to as ” Apt Medical Inc(688617) ” or “company”) for initial public offering and listing on the science and innovation board, According to the measures for the administration of securities issuance and listing recommendation business, the guidelines for the continuous supervision of listed companies of Shanghai Stock Exchange, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies, the Listing Rules of shares on the science and innovation board of Shanghai Stock Exchange (revised in December 2020) and the measures for the continuous supervision of listed companies on the science and Innovation Board (Trial) And other relevant regulations, conducted special verification on the storage and use of the raised funds in Apt Medical Inc(688617) 2021, and the verification results are as follows: I. Basic information of the raised funds (I) actual amount of the raised funds and the time when the funds are in place
With the approval of zjfzz [2020] No. 3359 document of China Securities Regulatory Commission, the company has publicly issued 16.67 million RMB common shares (A shares) (with a par value of RMB 1 per share) at an issue price of RMB 74.46 per share, with a total amount of raised funds of RMB 124820000, After deducting the company’s recommendation and underwriting fees excluding value-added tax and other issuance expenses, the net amount of funds raised is 115071782525 yuan. The availability of the above raised funds was verified by Lixin Certified Public Accountants (special general partnership), which issued the capital verification report ([2021] No. za10001) on January 4, 2021.
After the raised funds are received, the company has stored the raised funds in a special account, and signed relevant regulatory agreements with the sponsor and the commercial bank storing the raised funds. (II) use of raised funds
As of December 31, 2021, the company has accumulated 2773167 yuan of raised funds, and the balance of raised funds is 20904654634 yuan. Details are as follows:
Unit: yuan currency: RMB
Project amount
Total raised funds 124820000
Less: payment of issuance related expenses 9053037475
Net proceeds 115071782525
Less: amount of raised funds used in raised investment projects (including replacement of early investment amount) 2773167
Including: vascular interventional medical device industrialization upgrading project 9204090268
Research and development project of vascular interventional medical devices 4625449130
Supplementary working capital 13443233769
Plus: accumulated interest income and investment income net of handling charges 905645276
Closing balance of special account for raised funds 67800000000
Including: closing balance for cash management: 20904654634
2、 Management of raised funds (I) management system of raised funds
In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies and other relevant laws, regulations and normative documents, and in combination with the actual situation of the company, the company has formulated the Apt Medical Inc(688617) raised funds management system, which is responsible for the deposit and use of raised funds Specific and clear provisions have been made in terms of use and supervision. (II) supervision agreement of raised funds
In accordance with the measures for the administration of funds raised by listed companies of Shanghai Stock Exchange and the provisions of relevant laws and regulations, the company, Hunan eput Medical Devices Co., Ltd., the subsidiary implementing the raised investment project The sponsor Citic Securities Company Limited(600030) and the commercial bank with the special account to store the raised funds signed the tripartite supervision agreement on the special account for raised funds and the quadripartite supervision agreement on the special account for raised funds, which stipulated the relevant responsibilities and obligations of all parties in detail. As of December 31, 2021, the company has deposited and used the raised funds in strict accordance with the provisions of the regulatory agreement. (III) storage of raised funds in special account
As of December 31, 2021, the balance of the company’s special account for raised funds is as follows:
Unit: yuan currency: RMB
Deposit method balance of account opening bank account number of account opening entity
Hunan eput Medical Equipment Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 4403040160 Shenzhen Sed Industry Co.Ltd(000032) 8 current 155908015 Co., Ltd. Shenzhen Longgang sub branch 274
Deposit method balance of account opening bank account number of account opening entity
Hunan eput Medical Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 440304016 Shenzhen Sed Industry Co.Ltd(000032) 8 current 3030923468 Co., Ltd. Shenzhen Longgang sub branch 290
Shenzhen Apt Medical Inc(688617) Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 440304016 Shenzhen Sed Industry Co.Ltd(000032) 3 current 49314625 Co., Ltd. Shenzhen Longgang sub branch 184
Shenzhen Apt Medical Inc(688617) Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 440304016 Shenzhen Sed Industry Co.Ltd(000032) 3 current 3835703 Co., Ltd. Shenzhen Longgang sub branch 192
Shenzhen Apt Medical Inc(688617) Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 440304016 Shenzhen Sed Industry Co.Ltd(000032) 3 current 8570571191 Co., Ltd. Shenzhen Longgang sub branch 200
Shenzhen Apt Medical Inc(688617) Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 440304016 Shenzhen Sed Industry Co.Ltd(000032) 5 current 8647380995 Co., Ltd. Shenzhen Longgang sub branch 429
Hunan Apt Medical Inc(688617) Instrument Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. 4403040160000336 current 446720637 Company Shenzhen Longgang sub branch 517
Total 20904654634
3、 Actual use of raised funds in this year (I) use of funds for investment projects with raised funds (hereinafter referred to as “raised investment projects”). During the reporting period, the company actually used raised funds of RMB 272727700. See Schedule 1 comparison table of use of raised funds for details.
(II) early investment and replacement of raised investment projects
The raised funds have been invested in advance before the company’s self raised funds are used. As of January 27, 2021, the company has invested 175532 million yuan in projects invested with raised funds in advance with self raised funds. The specific application is as follows:
Unit: 10000 yuan currency: RMB
Use the raised funds to invest in self raised funds in advance. It is proposed to replace the item name of the pre invested serial number. The amount is included in the amount of self raised funds
1. Industrialization upgrading project of vascular interventional medical devices 36761769.63 769.63
2. R & D project of vascular interventional medical devices 33869985.69 985.69
3 supplementary working capital 13419 —
Total 84049175532175532
Lixin Certified Public Accountants (special general partnership) issued the special verification report of Apt Medical Inc(688617) raised capital replacement (xksbz [2021] No. za10326) on the matters that the company invested the raised capital investment projects in advance with self raised funds. The above matters were deliberated and adopted at the 11th meeting of the first board of directors and the 9th meeting of the first board of supervisors on April 6, 2021. The independent directors of the company issued independent opinions with explicit consent and fulfilled the necessary decision-making procedures. The sponsor Citic Securities Company Limited(600030) issued verification opinions on the above matters. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on April 7, 2021 The Apt Medical Inc(688617) announcement on the company’s use of raised funds to replace self raised funds invested in advance was disclosed. (III) temporary replenishment of working capital with idle raised funds
During the reporting period, the company did not temporarily supplement working capital with idle raised funds. (IV) cash management of idle raised funds and investment in related products
On January 7, 2021, the company held the eighth meeting of the first board of directors and the sixth meeting of the first board of supervisors, deliberated and approved the proposal on using part of the temporarily idle raised funds for cash management, and agreed that the company should use the temporarily idle raised funds of no more than RMB 1.1 billion (including this amount) for cash management, which is used to purchase investment with high safety, good liquidity Principal guaranteed financial products or deposit products (including but not limited to agreement deposits, structured deposits, time deposits, large certificates of deposit, call deposits, etc.). Investment products shall not be used for pledge, and the special settlement account for products (if applicable) shall not deposit non raised funds or be used for other purposes. The service life shall not exceed 12 months from the date of deliberation and approval by the board of directors of the company. Within the above limit and validity period, the funds can be used in a circular and rolling manner. The above limit refers to that the maximum balance of cash management on a single day does not exceed RMB 1.1 billion (including this amount). At the same time, the management of the company is authorized to handle matters related to cash management of idle raised funds, and the specific matters shall be organized and implemented by the financial department of the company. For details, please refer to the company’s disclosure on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 8, 2021 Announcement of Apt Medical Inc(688617) on cash management using some temporarily idle raised funds.
On December 15, 2021, the company held the 15th meeting of the first board of directors and the 13th meeting of the first board of supervisors, deliberated and approved the proposal on using part of the temporarily idle raised funds for cash management, and agreed that the company would use the temporarily idle raised funds of no more than RMB 900 million (including this amount) for cash management to purchase investment with high safety Financial products or deposit products with good liquidity and guaranteed principal (including but not limited to agreement deposits, structured deposits, time deposits, large certificates of deposit, call deposits, etc.). Investment products shall not be used for pledge, and the special settlement account for products (if applicable) shall not deposit non raised funds or be used for other purposes. The service life shall not exceed 12 months from the date of deliberation and approval by the board of directors of the company. Within the above limit and validity period, the funds can be recycled and used in a rolling manner. The above limit refers to that the maximum balance of cash management on a single day does not exceed RMB 900 million (including this amount). with
